PeptidePlus BPC-157 (5 mg)

The Ultimate "Body Protective Compound" for Repair & Recovery

BPC-157 is a powerful synthetic peptide composed of 15 amino acids (a pentadecapeptide). Its name stands for "Body Protective Compound," inspired by a protein naturally occurring in human gastric juices. While the body produces it in trace amounts to protect the GI tract, concentrated BPC-157 has gained global attention for its unparalleled regenerative properties across nearly all biological tissues.

Each 5 mg vial provides a high-purity, stable sequence designed for those seeking to accelerate healing from sports injuries, chronic inflammation, and digestive distress.

How BPC-157 Works: The Science of Regeneration

BPC-157 is often referred to as a "Stable Gastric Pentadecapeptide." Unlike many other peptides, it remains stable in the presence of harsh stomach acids, allowing for high biological activity. It functions primarily through two pathways:

1. Angiogenesis: It promotes the formation of new blood vessels, ensuring that damaged tissues receive the oxygen and nutrients necessary for repair.

2. Nitric Oxide (NO) Modulation: By interacting with the NO system, it protects endothelial tissue and creates a potent anti-inflammatory environment.

Key Benefits & Applications

• Tendon & Ligament Repair: Highly effective at healing Achilles tendon tears, MCL damage, and other connective tissue injuries by promoting cell migration and growth.

• Gastrointestinal Healing: Known to repair damage from Inflammatory Bowel Disease (IBD) and leaky gut, and can even reverse the harmful effects of long-term NSAID (painkiller) use on the stomach lining.

• Muscle & Bone Support: Research indicates BPC-157 can accelerate the healing of crushed muscles and segmental bone defects.

• Systemic Anti-Inflammatory: Offers a therapeutic effect on inflammation throughout the body, helping to preserve tissue integrity even in impaired conditions.

Usage & Dosage Guidelines

While scientific consensus is still evolving, common research protocols often utilize the following:

• Pack Size: 5 mg Lyophilized Powder.

• Standard Dosage: Typically 200 mcg to 800 mcg per day.

• Popular Protocol: Many users report success with 250–350 mcg administered twice daily (totaling 500–700 mcg/day).

• Administration: Can be administered via Subcutaneous (SubQ) injection or orally, due to its unique stability in gastric environments.

Storage & Stability

• Before Reconstitution: Store in a cool, dark place (Freezer for long-term storage).

• After Reconstitution: Once mixed with bacteriostatic water, it must be refrigerated. For maximum potency, use the vial within 3–4 weeks.

Frequently Asked Questions (FAQ)

1. Why isn't BPC-157 a standard prescription drug?

Because BPC-157 is derived from a natural sequence found in human gastric juice, it is difficult to patent in its natural form. Without the incentive of a patent, major pharmaceutical companies rarely fund the multi-million dollar human clinical trials required for FDA approval.

2. Is BPC-157 legal for athletes?

Currently, BPC-157 is not explicitly listed on the WADA/USADA prohibited list under specific categories like "growth factors," but regulations are constantly evolving. Athletes should always check the most current "S3 Gene and Cell Doping" and "S2 Peptide Hormones" sections of the prohibited list.

3. Can I take it with other supplements?

BPC-157 is often stacked with TB-500 for a synergistic effect on injury recovery. While BPC-157 focuses on local healing and angiogenesis, TB-500 excels at systemic tissue repair and flexibility.

BPC-157 Hubio Pharma

BPC-157 is a powerful synthetic peptide composed of 15 amino acids (a pentadecapeptide). Its name stands for "Body Protective Compound," inspired by a protein naturally occurring in human gastric juices. While the body produces it in trace amounts to protect the GI tract, concentrated BPC-157 has gained global attention for its unparalleled regenerative properties across nearly all biological tissues.

Each 5 mg vial provides a high-purity, stable sequence designed for those seeking to accelerate healing from sports injuries, chronic inflammation, and digestive distress.

How BPC-157 Works: The Science of Regeneration

BPC-157 is often referred to as a "Stable Gastric Pentadecapeptide." Unlike many other peptides, it remains stable in the presence of harsh stomach acids, allowing for high biological activity. It functions primarily through two pathways:

1. Angiogenesis: It promotes the formation of new blood vessels, ensuring that damaged tissues receive the oxygen and nutrients necessary for repair.
2. Nitric Oxide (NO) Modulation: By interacting with the NO system, it protects endothelial tissue and creates a potent anti-inflammatory environment.

Key Benefits & Applications

• Tendon & Ligament Repair: Highly effective at healing Achilles tendon tears, MCL damage, and other connective tissue injuries by promoting cell migration and growth.
• Gastrointestinal Healing: Known to repair damage from Inflammatory Bowel Disease (IBD) and leaky gut, and can even reverse the harmful effects of long-term NSAID (painkiller) use on the stomach lining.
• Muscle & Bone Support: Research indicates BPC-157 can accelerate the healing of crushed muscles and segmental bone defects.
• Systemic Anti-Inflammatory: Offers a therapeutic effect on inflammation throughout the body, helping to preserve tissue integrity even in impaired conditions.

Usage & Dosage Guidelines

While scientific consensus is still evolving, common research protocols often utilize the following:

• Pack Size: 5 mg Lyophilized Powder.
• Standard Dosage: Typically 200 mcg to 800 mcg per day.
• Popular Protocol: Many users report success with 250–350 mcg administered twice daily (totaling 500–700 mcg/day).
• Administration: Can be administered via Subcutaneous (SubQ) injection or orally, due to its unique stability in gastric environments.

Storage & Stability

• Before Reconstitution: Store in a cool, dark place (Freezer for long-term storage).
• After Reconstitution: Once mixed with bacteriostatic water, it must be refrigerated. For maximum potency, use the vial within 3–4 weeks.

Frequently Asked Questions (FAQ)

1. Why isn't BPC-157 a standard prescription drug? Because BPC-157 is derived from a natural sequence found in human gastric juice, it is difficult to patent in its natural form. Without the incentive of a patent, major pharmaceutical companies rarely fund the multi-million dollar human clinical trials required for FDA approval.

2. Is BPC-157 legal for athletes? Currently, BPC-157 is not explicitly listed on the WADA/USADA prohibited list under specific categories like "growth factors," but regulations are constantly evolving. Athletes should always check the most current "S3 Gene and Cell Doping" and "S2 Peptide Hormones" sections of the prohibited list.

3. Can I take it with other supplements? BPC-157 is often stacked with TB-500 for a synergistic effect on injury recovery. While BPC-157 focuses on local healing and angiogenesis, TB-500 excels at systemic tissue repair and flexibility.

BPC-157 Sixpex USA

Source: BPC-157 (Sixpex USA)

Active Component: Stable Gastric Pentadecapeptide (15 amino acid sequence)

What is BPC-157?

BPC-157, or "Body Protect Compound," is a naturally occurring peptide found in trace amounts within human gastric juice, where its function is to protect and heal the intestinal tract. However, when synthesized and administered in a concentrated form, BPC-157 demonstrates extremely potent biological healing activity throughout the entire body.

The peptide is known as a stable gastric pentadecapeptide because its fifteen amino acid sequence remains structurally intact and effective even in harsh human gastric juice.

 Broad Spectrum Healing and Regeneration

Extensive research, largely conducted since 1991, has shown BPC-157 to be remarkably effective in the repair and regeneration of numerous tissues with a favorable side effect profile.

Musculoskeletal and Connective Tissue Repair

• Tendon and Ligament Healing: Studies demonstrate its ability to promote the healing of tendons (e.g., Achilles tears) and ligaments (e.g., medial collateral ligaments) by stimulating tendon growth, cell survival, and cell migration. It effectively promotes healing from tendon to bone.

• Muscle Repair: It has been shown to reverse damage and accelerate healing in muscle tissue, even when compromised by systemic factors like corticosteroid use (demonstrated in rodent models of crushed gastrocnemius muscles).

• Bone Healing: BPC-157 promotes bone healing, even in cases of significant segmental bone defects.

Gastrointestinal and Anti-Inflammatory Effects

• GI Tract Protection: It provides powerful ulcer-preventive effects and anabolic healing throughout both the upper and lower gastrointestinal (GI) tract.

• IBD and Painkiller Damage: It rapidly repairs damage from inflammatory bowel disease (IBD) and successfully eliminates the harmful effects of common painkillers on the GI tract.

• Wound Healing: It significantly accelerates general wound healing. Through interaction with the Nitric Oxide (NO) system, it promotes angiogenesis (the formation of new blood vessels), aiding tissue preservation even in compromised conditions.

 Dosage and Administration (Anecdotal Data)

While BPC-157 research supports systematic effectiveness, standardized human clinical doses are still being established. Dosages based on research and anecdotal experience are typically:

• General Systemic Dosage: Research suggests a range of 1–10 mcg per kilogram of body weight once per day.

• Common User Dosing: Anecdotal reports suggest that a total daily dose between 500 mcg and 700 mcg, often split into two injections per day (e.g., 250–350 mcg twice daily), is most effective for promoting systemic healing.

 Status and Important Disclaimers

BPC-157’s status as a naturally occurring peptide leads to specific challenges and considerations:

Patent Status and Research Limitation

Because BPC-157 is a natural gastric juice peptide, it cannot be patented. This lack of patent protection means large pharmaceutical companies have no financial incentive to fund the extensive, long-term human studies required for FDA drug approval. Consequently, the majority of existing research comes from a limited group of earlier studies.

Regulatory and Sports Status

• FDA Approval: BPC-157 is not currently approved by the FDA as a drug for human therapeutic use.

• WADA/USADA Status: While specific "peptide hormones, growth factors, related substances, and mimetics" are banned by organizations like USADA and WADA, BPC-157 is not currently listed as an illegal compound. Users should, however, remain vigilant as regulatory lists are subject to change.

• Human Data: Despite its strong track record in animal models, there have been no long-term human studies to date. Users should be aware that the safety profile is extrapolated largely from in vitro and in vivo animal research.

BPC-157 Deus Medical

Active Component: BPC-157 Pentadecapeptide (5 mg/vial)

Manufacturer: Deus Medical

Pack: 1 Vial x 5 mg

What Is BPC-157?

BPC-157, or "Body Protect Compound," is a naturally occurring peptide—a stable gastric pentadecapeptide—originally found in trace amounts within human gastric juices, where it serves to protect and heal the intestinal tract. When synthesized in a super-concentrated form, it demonstrates extremely high biological healing activity across various bodily systems.

Its long chemical name reflects its fifteen amino acid sequence, which remains stable even in harsh conditions, allowing it to exert anabolic healing effects in both the upper and lower GI tract.

Broad Spectrum Healing and Regeneration

Extensive research, largely conducted in rodent models since 1991, has shown BPC-157 to be remarkably effective in the repair and regeneration of numerous tissues with a favorable side effect profile.

Musculoskeletal and Connective Tissue Repair

• Tendon and Ligament Healing: It promotes the healing of tendons (e.g., Achilles tears) and ligaments (e.g., damaged medial collateral ligaments) by stimulating tendon growth, cell survival, and cell migration. It is shown to promote healing from tendon to bone.

• Muscle and Bone Repair: BPC-157 reverses systemic corticosteroid-damaged muscle healing and promotes bone healing in models with segmental defects.

• Wound Healing: It accelerates general wound healing and, through interaction with the Nitric Oxide (NO) system, promotes angiogenesis (new blood vessel formation).

Gastrointestinal and Anti-Inflammatory Effects

• GI Tract Protection: It provides powerful ulcer-preventive effects and repairs damage from inflammatory bowel disease (IBD) within days after administration.

• Painkiller Damage: It effectively eliminates the harmful effects of common painkillers on the gastrointestinal tract.

 Dosage and Administration (Research and Anecdotal)

While BPC-157 is widely researched, standardized human clinical doses are still being established.

• Research Dosage: Systematically effective doses are shown to range between 1–10 mcg per kilogram of body weight once a day, which usually translates to 200 mcg to 800 mcg total daily.

• Anecdotal Dosage: Many users report success with doses of 250–350 mcg twice a day, totaling 500–700 mcg daily.

 Status and Important Disclaimers

• Non-Patentable Status: Because BPC-157 is a natural peptide, it cannot be patented. This lack of financial incentive explains why it is not marketed to doctors and is not approved by the FDA as a drug for human use.

• Research Status: There have been no long-term human studies to date, and 90% of the studies originated from one initial Croatian clinical study.

• WADA/USADA Status: While some peptides are banned, BPC-157 is not currently listed as an illegal compound by organizations like WADA or USADA. Users should be aware that this status can change.

 Frequently Asked Questions (FAQs)

1. Why hasn't BPC-157 been approved by the FDA if the research shows such positive healing effects?

BPC-157 has not received FDA approval because it is a naturally occurring peptide and therefore cannot be patented. Without patent protection, major pharmaceutical companies lack the financial incentive to invest hundreds of millions of dollars into the mandatory, large-scale, long-term human clinical trials required for drug approval.

2. Is BPC-157 generally taken orally or via injection?

While BPC-157 is stable in gastric juice (making oral administration possible for GI tract issues), it is generally considered more systematically effective when injected (subcutaneously or intramuscularly). Injections deliver the super-concentrated peptide directly into the system or near the site of injury for maximum localized biological healing activity.

3. What is the difference between BPC-157 and BPC-157 Arg?

The difference lies in the formulation's stability. While BPC-157 is known as the stable gastric pentadecapeptide, the Arginine salt form (BPC-157 Arg) is a newer version designed for even greater stability and bioavailability, particularly in acidic environments or when stored as a powder.

4. What is the risk associated with BPC-157 promoting cell growth and healing?

The risk, though not fully established in human studies, lies in its ability to stimulate angiogenesis (new blood vessel formation) and cell growth. If an individual has undiagnosed or existing cancerous conditions, the component's regenerative action could theoretically promote the growth or spread of cancer cells. For this reason, anyone with a history of cancer should strictly avoid its use.

BPC-157 2mg Driada Medical EU
 

BPC-157 Pentadecapeptide for Research: 2mg Vial (HPLC Verified)

This premium BPC-157 pentadecapeptide is a highly stable, synthetic 15-amino acid sequence derived from a body protection compound found in human gastric juice. It is extensively studied in tissue repair and regenerative medicine research applications. Each box contains 1 vial of 2mg BPC-157 and sterile water for reconstitution, ensuring optimal preparation for your laboratory studies.

 Key Research Characteristics

BPC-157 is a robust research chemical known for its stability and potential versatility in diverse biological models.

• Powerful Tissue Repair Potential: Primary research focus is on BPC-157's regenerative properties across various tissue types, including connective tissues and muscle.

• Highly Stable Formula: Its structure demonstrates resilience in research environments, making it a reliable compound for long-term studies.

• Versatile Research Application: Investigated for use in numerous models, making it a key peptide for muscle recovery, ligament repair, and gastrointestinal research.

• Guaranteed High Purity: Each batch is HPLC-verified with specific certificates of analysis available, confirming purity for accurate and reliable results.

 Primary Research Applications of BPC-157

Researchers utilize the BPC-157 peptide in a wide range of in vivo and in vitro models:

• Tendon and Ligament Repair Models: Extensive studies investigate its role in accelerating the healing of connective tissue, which is highly relevant for orthopedic research.

• Muscle Recovery Studies: Potential applications for accelerating muscle tissue regeneration and reducing downtime in performance-related research.

• Gastrointestinal Tissue Research: Relevant for models exploring mucosal protection and the healing of the GI tract lining (stomach and intestines).

• Wound Healing Investigations: Research into its mechanisms for enhancing general skin and tissue repair following injury.

 Who Uses BPC-157 in Research?

The BPC-157 pentadecapeptide is primarily used by scientists, researchers, and academic institutions across various fields of biological and medical science.

Key groups who use BPC-157 in their research protocols include:

• Orthopedic and Sports Medicine Researchers: Investigating its effects on the healing rate and strength of tendons, ligaments, and bone.

• Gastroenterologists and GI Researchers: Studying its protective and healing properties on the gastric and intestinal mucosa (the lining of the digestive tract).

• Biochemists and Molecular Biologists: Exploring the peptide's mechanisms of action, such as its interaction with growth factors (like Vascular Endothelial Growth Factor or VEGF) and its role in promoting tissue vascularity.

• Wound Care and Regenerative Medicine Specialists: Using BPC-157 in models to understand its potential to accelerate wound closure and improve the quality of scar tissue.

 Frequently Asked Questions (FAQ) about BPC-157 Pentadecapeptide

1. What is BPC-157 derived from?

BPC-157 is a synthetic pentadecapeptide, meaning it is a chain of 15 amino acids. It is derived from a naturally occurring Body Protection Compound (BPC) found in human gastric juice.

2. Is BPC-157 for human use or therapeutic treatment?

No. BPC-157 is sold strictly as a research chemical for in vitro (cell culture) and in vivo (animal model) studies only. It is not approved for human consumption, therapeutic use, or dietary supplementation by regulatory bodies like the FDA and is banned by WADA (World Anti-Doping Agency) as an unapproved substance.

3. How should BPC-157 be stored?

BPC-157 is typically supplied as a lyophilized (freeze-dried) powder. The sealed vial should be stored in a cool, dark place (e.g., refrigerator) to maintain its stability. Once reconstituted with sterile water, the solution should be refrigerated and typically used within a short period, as recommended by the supplier's research guidelines.

4. What is the purity of the BPC-157 supplied?

The BPC-157 is supplied at a high purity level, typically verified to be over 99% by High-Performance Liquid Chromatography (HPLC). A batch-specific Certificate of Analysis (COA) is available to confirm the exact purity for research quality assurance.

5. What are the main areas of research involving BPC-157?

The primary research applications focus on its potential role in tissue repair and regeneration. Studies suggest mechanisms involving enhanced growth factor signaling (like VEGFR2-Akt-eNOS pathway) and increased expression of the Growth Hormone Receptor (GHR) in fibroblasts

BPC-157 Pentadecapeptide 10mg/vial
 

1 Box of 1 Vial + water

BPC-157 is a synthetic peptide sequence that has been the subject of various scientific studies investigating its potential role in tissue repair and recovery processes. This 15-amino acid compound is derived from a protective protein found in gastric juice.

Key Research Characteristics

 Tissue Repair Studies - Investigated for potential regenerative properties
 Stable Formula - Demonstrated resilience in research environments
 Versatile Application - Studied across multiple tissue types
 High Purity - HPLC-verified, batch-specific certificates available

Research Applications

• Tendon and ligament repair models

• Muscle recovery studies

• Gastrointestinal tissue research

• Wound healing investigations

BPC-157 Pentadecapeptide 50 mg
 

Manufacturer: Purple Top

Active Substance: BPC-157 (Body Protect Compound)

Pack Size: 10 vials x 5 mg

Total Content: 50 mg

Form: Lyophilized powder (for reconstitution)

This high-purity BPC-157 peptide (Body Protect Compound) is offered by Purple Top in a concentrated, multi-vial pack suitable for extensive laboratory and preclinical studies. Each pack contains 10 vials x 5mg of BPC-157.

BPC-157 is an extremely stable synthetic peptide sequence that is actively researched for its remarkable regenerative and cytoprotective properties.
 

BPC-157: The Body Protect Compound
 

BPC-157 is a 15-amino acid sequence that is a fragment of a larger protective protein naturally found in human gastric juices. Its full chemical designation highlights its complexity:

• Long Chemical Name: L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylgsil-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leucine; glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglisilsil-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leusil-L-valine.

• Action: When isolated and highly concentrated, the compound exhibits extremely high biological healing activity in various systemic and local applications within research models.

Key Research Findings and Applications

Since 1991, extensive in vitro (test tube) and in vivo (rodent) studies have demonstrated BPC-157's potential to facilitate repair in numerous tissue types:
 

1. Musculoskeletal and Connective Tissue Repair
 

• Tendon & Ligament Healing: Shown to promote tendon growth, cell survival, and cell migration. Studies in rodent models demonstrate accelerated healing of damaged Achilles tendons and medial collateral ligaments.

• Muscle Regeneration: Successfully reversed systemic corticosteroid-damaged muscle healing in rodent models (e.g., crushed gastrocnemius muscles).

• Bone Healing: Promotes accelerated repair in models involving segmental bone defects (demonstrated in rabbits).

• Mechanism: Facilitates healing from tendon to bone junctions.
   

2. Gastrointestinal (GI) and Cytoprotective Effects

• Inflammatory Bowel Disease (IBD): Repaired damage from IBD in rodent models within days following oral application.

• Anti-Ulcer & Protection: Known as a "stable gastric pentadecapeptide," it exhibits strong ulcer-preventive effects and eliminates the harmful effects of certain painkillers on the GI tract.

• GI Tract Healing: Causes anabolic healing effects throughout both the upper and lower GI tract.
   

3. Wound Healing and Angiogenesis

• BPC-157 accelerates general wound healing.

• It interacts with the Nitric Oxide (NO) system to promote the preservation of endothelial tissue and an angiogenic (blood vessel forming) wound healing effect.
   

Research Dosing Parameters (Anecdotal)

While this product is sold for research purposes only, systematic effectiveness in animal models has been reported with injections in the range of 1-10 micrograms  per kilogram of body weight once a day.

Anecdotal reports among research communities suggest successful total daily doses often range from 200 micrograms to 800 micrograms, with some citing success at 250-350 micrograms twice a day (500-700 micrograms total). Note: There is no common scientific consensus on human dosage, and these figures are for informational context only.

Regulatory and Patent Context

• Non-Patentability: BPC-157, being a natural gastric juice peptide, cannot be patented, which has limited major pharmaceutical development and marketing.

• FDA Status: BPC-157 is not approved by the FDA as a drug for human use.

• WADA/USADA: While some related peptide hormones are banned, BPC-157 is not currently listed as an illegal compound by WADA or USADA.

Important Note for Researchers

This BPC-157 product is intended strictly for research purposes and laboratory use. It is not for human consumption, therapeutic use, or non-research applications. The majority of existing research is from preclinical studies, and long-term human safety data is currently unavailable.

BPC 157 0.5 – Beligas Pharma USA (100 Oral Tablets, 0.5mg per Tab)

Product Description:

BPC 157 0.5 by Beligas Pharma USA is an innovative oral peptide supplement containing Body Protection Compound-157 (BPC-157) at 0.5mg per tablet, supplied in a 100-tablet pack. BPC 157 is a synthetic peptide derived from gastric proteins, widely researched for its healing, recovery, and regenerative properties.

Athletes and bodybuilders use BPC 157 to accelerate muscle recovery, protect joints, and support gut health. Unlike many peptides, it demonstrates powerful tissue-healing properties that may benefit those recovering from injuries, inflammation, or physical stress.

Key Features

• Active Ingredient: BPC 157 (Body Protection Compound-157)

• Strength: 0.5mg per tablet

• Pack Size: 100 Tablets

• Form: Oral tablets

• Brand: Beligas Pharma USA

What is BPC 157?

BPC 157 is a synthetic peptide originally developed for research in gut protection and tissue repair. In the performance and wellness community, it is valued for:

• Accelerating healing of muscles, tendons, and ligaments.

• Reducing inflammation in joints and tissues.

• Supporting gut health and recovery from gastrointestinal issues.

• Improving injury recovery time for athletes.

Because it can be taken orally or via injection, BPC 157 is one of the most versatile recovery peptides available.

Benefits of BPC 157 0.5 (Oral Use)

1. Speeds up recovery from sports injuries and muscle strain.

2. Supports joint and tendon health – reduces pain and stiffness.

3. Promotes gut healing – may aid digestive health.

4. Reduces systemic inflammation – supports overall wellness.

5. Convenient oral administration – easy daily dosing.

Dosage and Administration

• Typical Oral Dosage: 500–1000mcg (1–2 tablets) daily

• Cycle Duration: 4–12 weeks, depending on goals

• Administration: Oral tablets, swallowed with water

⚠️ Research suggests BPC 157 is highly safe, but dosage should be adjusted based on individual tolerance.

Possible Side Effects

BPC 157 is generally well tolerated, with very few reported side effects. Rare cases may include:

• Mild nausea

• Temporary digestive discomfort

• Headaches (dose-dependent)

Friendly Suggestion

Since many UGL peptides and supplements can be under-dosed or inaccurately labeled, always choose trusted brands and check community reviews on Reddit, Trustpilot, or bodybuilding forums before purchasing.

And remember—BPC 157 works best as part of a recovery plan, combined with proper nutrition, rest, and training adjustments.

BPC-157 XENO LABS USA

Body Protect Compound for Accelerated Healing & Tissue Repair

BPC-157 (Body Protect Compound) is an entirely natural gastric juice peptide, derived from a protein found in your own stomach. It is highly stable and resistant to human gastric juice, giving it the classification of a "stable gastric pentadecapeptide." Although the body produces BPC-157 in small amounts to protect and heal the intestines, the super-concentrated version exhibits extremely high biological healing activity wherever it is applied.

The full fifteen amino acid sequence is notably complex: L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylgsil-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leucine; glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglisilsil-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leusil-L-valine.

Remarkable Healing & Anti-Inflammatory Benefits (Pre-Clinical Research)

Since 1991, extensive research (primarily in vitro and in vivo rodent studies) has demonstrated BPC-157's wide range of therapeutic effects:

• Musculoskeletal Repair: Promotes accelerated healing of tendons, ligaments, muscles, and bones. Demonstrated effective in rodent models with Achilles tendon tears and damaged medial collateral ligaments, promoting tendon growth and tendon-to-bone healing.

• Gastrointestinal Protection: Heals damage from Inflammatory Bowel Disease (IBD) within days after oral application in rodent models. It has ulcer-preventive effects and accelerates the return of intestinal anastomosis in severely impaired conditions.

• Painkiller Reversal: Eliminates the harmful effects of painkillers on the gastrointestinal tract.

• Counteracts Corticosteroid Damage: Reversed systemic corticosteroid-damaged muscle healing in rodents when administered orally.

• Angiogenic Effects: Accelerates wound healing through interaction with the Nitric Oxide (NO) system, promoting the preservation of endothelial tissue and the formation of new blood vessels ("angiogenic" effect).

Technical Specifications and Dosing

Dosage (Anecdotal Reports)

There is no common scientific consensus on human dosage, but systematic research in animals suggests effectiveness between 1–10 mcg per kilogram of body weight once a day. Anecdotal experiences suggest successful doses range from 200 mcg to 800 mcg anywhere, with some users reporting success at 250–350 mcg twice a day (total daily dose 500–700 mcg).

Important Regulatory and Legal Disclaimer

• FDA Status: BPC-157 is not approved by the FDA as a drug for human use.

• Patent Status: Because it is an entirely natural gastric juice peptide, it cannot be patented. Major pharmaceutical companies cannot market this substance, which is why your doctor, surgeon, or gastroenterologist has not informed you about it.

• WADA/USADA Status: The use of BPC-157 in sports is subject to strict regulation. While some "peptide hormones, growth factors, related substances, and mimetics" are prohibited, BPC-157 is not currently listed as one of these illegal compounds. (Note: This status is constantly reviewed by organizations like WADA and may change.)

• Human Safety Data: There have been no long-term human studies to date, and 90% of the research originated from the same clinical study.

BPC-157 10mg – Advanced Healing Peptide | 1 Vial Peptide + 1 Vial Sterile Water

Active Ingredient: BPC-157 (Body Protection Compound-157)
Pack: 1 Vial x 10mg + 1 Vial Sterile Water
Form: Injectable / Reconstitutable Peptide Solution

Overview

BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids that was originally derived from a naturally occurring compound found in human gastric juice. It is often referred to as the “stable gastric pentadecapeptide” because it remains active and stable in the digestive environment and exhibits a wide range of regenerative and protective properties throughout the body.

First identified in the early 1990s, BPC-157 has been widely studied in laboratory and animal models for its ability to accelerate tissue repair, enhance recovery, and reduce inflammation. Though it has not been approved for medical use in humans, it has become one of the most recognized research peptides for healing and recovery applications.

Amino Acid Structure

BPC-157 is composed of a 15-amino-acid sequence derived from a protective protein found in gastric secretions:
L-Valine – Glycyl-L-alpha-glutamyl – L-prolyl – L-prolyl – L-prolyl – L-lysyl – L-prolyl – L-alanyl – L-alpha-aspartyl – L-alpha-aspartyl – L-alanyl – Glycyl – L-leucine – L-valine.

This peptide sequence contributes to its biological stability, healing capacity, and anti-inflammatory properties, making it one of the most versatile regenerative peptides in scientific research.

How BPC-157 Works

BPC-157 functions by stimulating several key biological systems involved in tissue regeneration, inflammation control, and vascular health.

Mechanisms of Action:

• Promotes tendon and ligament healing: Enhances fibroblast activity, collagen formation, and blood vessel regeneration.

• Accelerates muscle and bone repair: Increases growth factor expression and cellular recovery following injury.

• Supports gastrointestinal protection: Helps repair intestinal damage and ulcers by maintaining epithelial integrity.

• Counteracts the harmful effects of NSAIDs (painkillers) on the stomach and gut lining.

• Stimulates angiogenesis: Encourages new blood vessel formation for faster wound and tissue healing.

• Interacts with the Nitric Oxide (NO) pathway: Enhances circulation and oxygenation at damaged sites.

In studies, BPC-157 has shown healing activity in tendons, ligaments, bones, skin, and intestinal tissues — even under conditions of extreme damage or inflammation.

Benefits of BPC-157

• Accelerates muscle, tendon, and ligament recovery

• Promotes faster bone healing

• Supports gut health and intestinal repair

• Reduces inflammation and oxidative stress

• Protects the liver and stomach from chemical or drug-induced damage

• Enhances vascularization and tissue regeneration

• May improve joint stability and pain recovery after injury

These effects have made BPC-157 a popular peptide among researchers exploring sports injury recovery, chronic inflammation, and post-surgical healing models.

Dosage and Administration (for Research Use Only)

In preclinical studies, BPC-157 has demonstrated effectiveness at doses ranging between 1–10 mcg per kilogram of body weight daily.

Typical Dosing Range (Experimental Use):

• Average daily dose: 200–800 mcg

• Alternative regimen: 250–350 mcg twice daily (500–700 mcg total)

Administration Method:

• Can be reconstituted with sterile bacteriostatic water.

• Typically administered subcutaneously (under the skin) near the site of injury.

• Injection should be performed using sterile, aseptic technique.

Note: These values are based on animal and in vitro research. There is no officially approved human dosing protocol.

Research Findings

Since 1991, numerous in vivo (animal) and in vitro (laboratory) studies have confirmed BPC-157’s regenerative potential.
Some of the most notable findings include:

• Tendon-to-bone repair: Promotes collagen formation and speeds recovery in tendon rupture models.

• Muscle regeneration: Reverses corticosteroid-induced muscle damage in rodent studies.

• Gut protection: Repairs intestinal and gastric lesions associated with inflammatory bowel disease (IBD).

• Bone healing: Enhances recovery from bone fractures and defects.

• Vascular repair: Restores endothelial integrity and stimulates angiogenesis.

Because BPC-157 is naturally derived, no significant toxic or adverse effects have been observed in research trials to date.

Safety and Legality

• Side Effects: None documented in scientific literature at standard research doses.

• Approval: BPC-157 is not approved by the FDA for human use.

• Legality: It is not currently listed as a prohibited substance by WADA or USADA.

• Regulatory Status: Sold strictly for research purposes and not intended for human consumption.

Summary

BPC-157 10mg Peptide represents a significant advancement in biological healing research. As a naturally occurring gastric peptide, it exhibits extraordinary regenerative potential across muscle, tendon, ligament, and gut tissues while showing a strong safety profile in preclinical studies.

Its broad healing properties, stability, and rapid recovery effects make it a focus of ongoing scientific exploration in the fields of sports medicine, tissue engineering, and regenerative biology.

BPC-157 – Beligas Pharma USA (Injectable Healing Peptide)

Product Description:

BPC-157 by Beligas Pharma USA is a high-quality injectable peptide formulated for tissue repair, recovery, and inflammation control. Originally derived from a protective protein found in the stomach, BPC-157 (Body Protection Compound-157) has been extensively researched for its ability to accelerate healing of muscles, tendons, ligaments, and even gut tissue.

Athletes, bodybuilders, and individuals recovering from injuries increasingly use BPC-157 for its remarkable regenerative effects and support in recovery protocols.

Key Features

• Active Ingredient: BPC-157 (Body Protection Compound-157)

• Form: Injectable peptide

• Administration: Subcutaneous or intramuscular injection

• Brand: Beligas Pharma USA

What is BPC-157?

BPC-157 is a synthetic peptide derived from gastric proteins, designed to promote cell regeneration and healing. It is known for:

• Accelerating soft tissue repair (muscles, tendons, ligaments).

• Reducing inflammation in damaged joints and tissues.

• Improving gut health and intestinal healing.

• Shortening recovery time from sports-related injuries.

Because it can be administered via injection, BPC-157 ensures fast delivery and high bioavailability, making it especially effective for targeted recovery.

Benefits of BPC-157 (Injectable Use)

1. Rapid healing of muscles, tendons, and ligaments.

2. Joint protection – reduces pain and stiffness.

3. Supports digestive and gut health.

4. Decreases systemic inflammation.

5. Speeds up recovery time after injury or surgery.

Dosage and Administration

• Typical Dosage: 200–500mcg per day

• Administration: Subcutaneous or intramuscular injection (near injury site for best effect)

• Cycle Duration: 4–6 weeks for injury recovery; longer for chronic issues

 Always reconstitute peptide with bacteriostatic water before injection.

Possible Side Effects

BPC-157 is considered very safe, with minimal reported side effects. Rare cases may include:

• Mild redness or irritation at the injection site

• Temporary nausea or dizziness

• Headache (dose-dependent)

Friendly Suggestion

Since many UGL peptides are under-dosed or misrepresented, always choose trusted brands and verify authenticity with Reddit, Trustpilot, or bodybuilding forum reviews.

And remember—BPC-157 works best as part of a full recovery plan, alongside proper rest, rehabilitation exercises, and nutrition.

Ingredient:Pentadecapeptide

Manufacturer:Ultima Pharmaceuticals

BPC-157 Pentadecapeptide 5mg/vial

1 Box of 1 Vial

Here is a fifteen amino acid sequence:

L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylgsil-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leucine; glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglisilsil-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leusil-L-valine. The long name of BPC-157 is this.

BPC stands for “body protect compound,” meaning the body already makes it in very small amounts in your own gastric juices, here serving to protect and heal your intestines. But if you can get the super-concentrated version into your system, it has extremely high biological healing activity in almost every place you put it.

What does it do?

BPC-157 is remarkably free of side effects and has been shown since 1991 in research to repair tendons, muscles, intestines, teeth, bones, and more, in both in vitro laboratory “test tube” studies and in vivo rodent studies.

It has been shown to promote tendon and ligament healing with tendon growth, cell survival, and cell migration when applied in drinking water to rodents with Achilles tendon tears in a rodent model and also with damaged medial collateral ligaments.

Healing from tendon to bone.

It eliminates the harmful effects of painkillers on the gastrointestinal tract.

It repairs damage from inflammatory bowel disease (IBD) in a rodent model of IBD within a few days after oral application.

It has reversed systemic corticosteroid-damaged muscle healing in rodent models when administered orally once daily for 14 days to rodents with crushed gastrocnemius muscles. Similar benefits were shown in a rodent study by Novinscak and colleagues.

It promotes bone healing in rabbits with segmental bone defects before treatment with BPC-157.

BPC-157 is also known as a "stable gastric pentadecapeptide" because it is stable in human gastric juice, can cause anabolic healing effects in both the upper and lower GI tract, has ulcer-preventive effects, and produces a therapeutic effect on inflammation.

As shown in the above research studies, BPC-157 also accelerates wound healing and through interaction with the Nitric Oxide (NO) system, promotes the preservation of endothelial tissue and an "angiogenic" (blood vessel forming) wound healing effect. This occurs even in severely impaired conditions such as advanced and poorly controlled irritable bowel disease, with the return of intestinal anastomosis.

How much should you take?

There is extensive research on BPC-157, and it has been shown to be systematically effective when injected anywhere between 1-10 mcg per kilogram of body weight once a day. In most cases, this amounts to a dose in the range of 200 mcg to 800 mcg anywhere. Some people report that doses of 250-350 mcg twice a day and a total daily dose of 500-700 mcg are most successful. Of course, these are anecdotal experiences and there is no common scientific consensus on this matter.

Summary

Okay, now you might be wondering why your doctor, physiotherapist, surgeon, gastroenterologist, etc. hasn't told you about these things.

Because BPC-157 is entirely a natural gastric juice peptide, it cannot be patented, period. This means that major pharmaceutical companies cannot make money from BPC-157, and it means that it is not marketed to any local doctor, hospital, or health system. It is also not approved by the FDA as a drug for human use.

You may also be wondering if sports governed by organizations like USADA or WADA are legal.

While some "peptide hormones, growth factors, related substances, and mimetics" are really illegal for use in sports governed by these organizations, BPC-157 is not currently listed as one of these illegal compounds. Not yet.

Despite being a peptide that you can find in your own gastric juices, there have been no long-term human studies to date, and 90% of the studies were from the same clinical study which was made by Croatia, a Croatian pharmaceutical company pliva was later bought by studies not done. hope understand